Case Page

 

Case Status:    SETTLED
On or around 08/01/2017 (Other)

Filing Date: March 01, 2013

According to the Complaint, Epocrates provides subscriptions for mobile drug
reference tools and electronic health records to healthcare professionals, as well as interactive services to the healthcare industry.

The Complaint alleges that Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts, about the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose: (1) that the Company's pharmaceutical clients were awaiting guidance relating to use of advertising on the Internet and through social media from the United States Food and Drug Administration ("FDA"); (2) that, as a result, the Company's pharmaceutical clients were increasingly delaying their marketing activities as they awaited guidance from the FDA; (3) the FDA's delays in issuing guidance relating to the Internet and social media was causing expanding regulatory queues for Epocrates; (4) that the expanding regulatory queues were negatively impacting the Company's sales and revenue growth; and (5) that, as a result of the foregoing, the Defendants' positive statements about the Company's business, operations, and prospects lacked a reasonable basis and/or were materially false and misleading at all relevant times.

On August 9, 2013, the Court issued an Order appointing lead plaintiff and approving the selection of lead counsel.

On October 8, 2013, the parties filed a Notice that Lead Plaintiff voluntarily dismisses their claims against certain defendants. On the same date, Lead Plaintiff filed an Amended Complaint.

On June 25, 2014, the Lead Plaintiff filed a Second Amended Complaint. A Third Amended Complaint was filed on October 23.

On March 13, 2015, the Court issued an Order denying Defendants' motion to dismiss.

COMPANY INFORMATION:

Sector: Technology
Industry: Computer Services
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: EPOC
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: N.D. California
DOCKET #: 13-CV-00945
JUDGE: Hon. Lucy H. Koh
DATE FILED: 03/01/2013
CLASS PERIOD START: 02/02/2011
CLASS PERIOD END: 08/09/2011
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Glancy Binkow & Goldberg LLP (Los Angeles)
    1801 Ave. of the Stars, Suite 311, Glancy Binkow & Goldberg LLP (Los Angeles), CA 90067
    310.201.915 310. 201-916 · info@glancylaw.com
  2. Scott + Scott LLP (NY)
    405 Lexington Avenue, 40th Floor, The Chrysler Building, Scott + Scott LLP (NY), NY 10174
    (212) 223-6444 (212) 223-6444 ·
No Document Title Filing Date
COURT: N.D. California
DOCKET #: 13-CV-00945
JUDGE: Hon. Lucy H. Koh
DATE FILED: 10/23/2014
CLASS PERIOD START: 02/01/2011
CLASS PERIOD END: 08/09/2011
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Glancy Binkow & Goldberg LLP (Los Angeles)
    1801 Ave. of the Stars, Suite 311, Glancy Binkow & Goldberg LLP (Los Angeles), CA 90067
    310.201.915 310. 201-916 · info@glancylaw.com
  2. Scott + Scott LLP (NY)
    405 Lexington Avenue, 40th Floor, The Chrysler Building, Scott + Scott LLP (NY), NY 10174
    (212) 223-6444 (212) 223-6444 ·
No Document Title Filing Date